Irritable bowel syndrome after Clostridioides difficile infection
Medicine and Pharmacy Reports · 31.07.2025 · 98 (3) · 320-324
DOI: 10.15386/mpr-2832 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicine and Pharmacy Reports, online erschienen am 31.07.2025. Verfasst von Teodora Iacob und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hospital for Infectious Diseases, Cluj-Napoca, Romania. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).
Abstract (Originalsprache)
Background
Irritable bowel syndrome (IBS) is a chronic functional disorder characterized by abdominal pain, bloating, and altered bowel habits. Postinfectious IBS (PI-IBS) develops after acute gastroenteritis, including Clostridioides difficile infection (CDI). While CDI has been shown to decrease in prevalence during the pandemic era, studies indicate a substantial risk of PIIBS following CDI, data remaining limited. The aim of the present study was to evaluate the risk of PI-IBS following a CDI and a potential correlation between PI-IBS onset and the severity of CDI.
Methods
This cross-sectional study included 69 patients hospitalized with suspected CDI at a tertiary center for Infectious Diseases, in Romania. Inclusion criteria were: patients >18 years of age with confirmed CDI via polymerase chain reaction. The severity of CDI was assessed based on hospitalization, laboratoryparameters, and clinical symptoms. PI-IBS was evaluated six months after CDI using the Rome IV IBS questionnaire and the Bristol Stool Form Scale. Relative risk (RR) was calculated using SPSS software and a p value
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hospital for Infectious Diseases, Cluj-Napoca, Romania.
- Department of Health Sciences, "Magna Graecia" University of Catanzaro, Italy.
- Medical Informatics and Biostatistics Department, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
- 2 Medical Department, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Zitieren
APA
Iacob, T., Scarlata, G. G. M., Abenavoli, L., Leucuţa, D. C., Lupşe, M. S., & Dumitraşcu, D. L. (2025). Irritable bowel syndrome after Clostridioides difficile infection. Medicine and Pharmacy Reports, 98(3), 320-324. https://doi.org/10.15386/mpr-2832
Vancouver
Iacob T, Scarlata GGM, Abenavoli L, Leucuţa DC, Lupşe MS, Dumitraşcu DL. Irritable bowel syndrome after Clostridioides difficile infection. Medicine and Pharmacy Reports. 2025;98(3):320-324. doi:10.15386/mpr-2832
BibTeX
@article{Iacob2025,
author = {Iacob, Teodora and Scarlata, Giuseppe Guido Maria and Abenavoli, Ludovico and Leucuţa, Daniel-Corneliu and Lupşe, Mihaela S and Dumitraşcu, Dan L},
title = {Irritable bowel syndrome after Clostridioides difficile infection},
journal = {Medicine and Pharmacy Reports},
year = {2025},
volume = {98},
number = {3},
pages = {320--324},
doi = {10.15386/mpr-2832}
}
EUVIMED